IDEA is a biopharmaceutical company focused on the area of dermatology and pain. It develops and commercialises non-invasive, targeted therapeutics based on stable, ultra-deformable carriers that are typically applied on the skin. These proprietary carriers are driven through the skin barrier by the local water gradient and can be engineered to achieve a high, localised drug concentration at the site of application and deep below.